Quick Answer
TEVA PHARMACEUTICAL INDUSTRIES LTD reported Total Assets of $40.75 billion for fiscal year 2025.
TEVA PHARMACEUTICAL INDUSTRIES LTD Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $40.75B | +3.6% |
| 2024 | $39.33B | -9.6% |
| 2023 | $43.48B | +3.3% |
| 2023 | $42.09B | -2.3% |
| 2023 | $43.10B | -0.8% |
| 2023 | $43.46B | -1.2% |
| 2022 | $44.01B | -0.5% |
| 2022 | $44.25B | -3.7% |
| 2022 | $45.93B | -3.6% |
| 2021 | $47.67B | -5.9% |
| 2020 | $50.64B | -11.9% |
| 2019 | $57.47B | -5.3% |
| 2018 | $60.68B | -14.1% |
| 2017 | $70.61B | -24.1% |
| 2016 | $93.06B | +71.6% |
| 2015 | $54.23B | +16.8% |
| 2014 | $46.42B | -2.3% |
| 2013 | $47.51B | -6.1% |
| 2012 | $50.61B | +0.9% |
| 2011 | $50.14B | +31.4% |
| 2010 | $38.15B | +14.9% |
| 2009 | $33.21B | +0.9% |
| 2008 | $32.92B | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $39.86B | -4.6% | -0.7% |
| June 30, 2025 | $40.13B | -2.9% | +4.5% |
| March 31, 2025 | $38.41B | -10.2% | -2.3% |
| December 31, 2024 | $39.33B | -9.6% | -5.8% |
| September 30, 2024 | $41.76B | -0.8% | +1.0% |
| June 30, 2024 | $41.34B | -4.1% | -3.4% |
| March 31, 2024 | $42.77B | -1.6% | -1.6% |
| December 31, 2023 | $43.48B | -1.2% | +3.3% |
- TEVA PHARMACEUTICAL INDUSTRIES LTD showed an increase of +3.6% in Total Assets compared to the prior fiscal year.
- Over the 2008–2025 period, TEVA PHARMACEUTICAL INDUSTRIES LTD’s total assets has grown by 23.8% (from $32.92 billion to $40.75 billion).
- The most recent figure is from TEVA PHARMACEUTICAL INDUSTRIES LTD’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: